Health AI Central
Share:
Peer-Reviewed Publication
J Am Geriatr Soc2023;71(7):2131-2140.July 1, 2023Journal Article

Systolic blood pressure, antihypertensive treatment, and cardiovascular and mortality risk in VA nursing home residents.

Xiaojuan Liu1,2, Michael A Steinman3,4, Sei J Lee3,4, Carmen A Peralta5,6, Laura A Graham7, Yongmei Li1,2, Bocheng Jing4, Kathy Z Fung3,4, Michelle C Odden1,2
1Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA.
2Geriatric Research Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California, USA.
3Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
4Geriatrics, Palliative, and Extended Care Service Line, San Francisco VA Medical Center, San Francisco, California, USA.
5Kidney Health Research Collaborative, University of California San Francisco and San Francisco VA Medical Center, San Francisco, California, USA.
6Cricket Health, Inc, San Francisco, California, USA.
7Health Economics Resource Center, VA Palo Alto Health Care System, Palo Alto, California, USA.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Optimal systolic BP (SBP) control in nursing home residents is uncertain, largely because this population has been excluded from clinical trials. We examined the association of SBP levels with the risk of cardiovascular (CV) events and mortality in Veterans Affairs (VA) nursing home residents on different numbers of antihypertensive medications. METHODS: Our study included 36,634 resi…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.